|
FY2026
12 months to Jul 31, 2026
|
FY2025
12 months to Jul 31, 2025
|
FY2024
12 months to Jul 31, 2024
|
FY2023
12 months to Jul 31, 2023
|
FY2022
12 months to Jul 31, 2022
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities: | |||||
| Net loss | |||||
| Less: Net loss from discontinued operations | |||||
| Net loss from continuing operations | |||||
| Adjustments to reconcile net loss to net cash provided by (used in) operating activities: | |||||
| Depreciation and amortization of property, plant and equipment | |||||
| Amortization of intangible assets | |||||
| Amortization of stock-based compensation | |||||
| Paid-in-kind interest under term loan | |||||
| Amortization of deferred financing costs, debt discount and accreted interest related to subordinated credit facility | |||||
| Loss on business divestiture | |||||
| Changes in other liabilities | |||||
| Amortization of deferred financing costs and debt discount related to credit facility | |||||
| Amortization of Costs to Fulfill Assets | |||||
| Write-off of deferred financing costs and debt discounts | |||||
| CEO transition costs related to equity-classified stock-based awards | |||||
| Change in fair value of convertible preferred stock purchase option liability | |||||
| Change in fair value of warrants and derivatives | |||||
| Loss on disposal of property, plant and equipment | |||||
| (Benefit from) provision for allowance for doubtful accounts and contract assets | |||||
| Provision for excess and obsolete inventory | |||||
| Deferred income tax expense (benefit) | |||||
| Impairment of long-lived assets, including goodwill | |||||
| Changes in assets and liabilities: | |||||
| Accounts receivable | |||||
| Inventories | |||||
| Prepaid expenses and other current assets | |||||
| Other assets | |||||
| Accounts payable | |||||
| Accrued expenses and other current liabilities | |||||
| Contract liabilities | |||||
| Other liabilities, non-current | |||||
| Interest payable | |||||
| Income taxes payable | |||||
| Net cash provided by (used in) operating activities from continuing operations | |||||
| Net cash provided by operating activities from discontinued operations | |||||
| Net cash provided by (used in) operating activities | |||||
| Cash flows from investing activities: | |||||
| Proceeds from business divestiture, net | |||||
| Purchases of property, plant and equipment | |||||
| Proceeds from sale of indefinite lived intangible assets | |||||
| Net cash used in investing activities from continuing operations | |||||
| Net cash provided by (used in) investing activities from discontinued operations | |||||
| Net cash used in investing activities | |||||
| Cash flows from financing activities: | |||||
| Net payments under revolving loans | |||||
| Repayment of term loan | |||||
| Repayment of subordinated credit facility | |||||
| Proceeds from subordinated credit facility | |||||
| Payment of deferred financing costs and debt discount | |||||
| Proceeds from issuance of convertible preferred stock | |||||
| Payment of convertible preferred stock issuance costs and fees | |||||
| Contribution for constructing long-lived assets | |||||
| Proceeds from term loan | |||||
| Net (payments) borrowings under revolving loans | |||||
| Payment of convertible preferred stock consent fee | |||||
| Payment of convertible preferred stock amendment fees | |||||
| Cash dividends paid on common stock | |||||
| Remittance of employees' statutory tax withholding for stock awards | |||||
| Proceeds from issuance of employee stock purchase plan shares | |||||
| Payment of shelf registration costs | |||||
| Shelf Registration | |||||
| Convertible Preferred Stock | |||||
| Total payment of shelf registration costs | |||||
| Repayment of principal amounts under finance lease and other obligations | |||||
| Net cash (used in) provided by financing activities from continuing operations | |||||
| Net (decrease) increase in cash and cash equivalents, including cash classified within current assets of discontinued operations held for sale | |||||
| Less: Net (decrease) increase in cash classified within current assets of discontinued operations held for sale | |||||
| Net (decrease) increase in cash and cash equivalents from continuing operations | |||||
| Cash and cash equivalents at beginning of year | |||||
| Cash and cash equivalents at end of year | |||||
| Supplemental cash flow disclosure (including discontinued operations) | |||||
| Interest | |||||
| Income taxes, net | |||||
| Non-cash investing and financing activities: | |||||
| Adjustment to reflect redemption value of convertible preferred stock | |||||
| Term loan amendment fees paid-in-kind | |||||
| Accrued term loan amendment fee | |||||
| Accrued additions to property, plant and equipment | |||||
| Issuance of restricted stock | |||||
| Common stock issued for acquisitions | |||||
| Establishment of initial convertible preferred stock purchase option liability | |||||
| Accrued remittance of employees' statutory tax withholdings for fully-vested share units | |||||
| Cash dividends declared on common stock but unpaid, including (reversal) accrual of dividend equivalents | |||||
| Reversal of dividend equivalents | |||||
| Accrued deferred financing costs | |||||
| Accrued shelf registration costs | |||||
| Unpaid convertible preferred stock issuance costs | |||||
| Accrued convertible preferred stock amendment fees | |||||
Loading...